EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY)

CUSIP: 29429X109

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM CL A
Total 13F shares
32,520,612
Share change
+165,527
Total reported value
$319,337,000
Put/Call ratio
92%
Price per share
$9.82
Number of holders
90
Value change
+$1,720,409
Number of buys
28
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 29429X109?
CUSIP 29429X109 identifies EPHY - EPIPHANY TECHNOLOGY ACQUISIT - COM CL A in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY) as of Q1 2022

As of 31 Mar 2022, EPIPHANY TECHNOLOGY ACQUISIT - COM CL A (EPHY) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,520,612 shares. The largest 10 holders included Saba Capital Management, L.P., ARISTEIA CAPITAL LLC, Linden Advisors LP, CITADEL ADVISORS LLC, HGC Investment Management Inc., MARSHALL WACE, LLP, Periscope Capital Inc., HBK INVESTMENTS L P, Polar Asset Management Partners Inc., and RP Investment Advisors LP. This page lists 90 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.